Japan· JP-3999448G3023
エタネルセプト（遺伝子組換え）［エタネルセプト後続１］
A medicinal product containing エタネルセプト（遺伝子組換え）［エタネルセプト後続１］, registered in Japan by 持田製薬, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- エタネルセプト（遺伝子組換え）［エタネルセプト後続１］
- Manufacturer
- 持田製薬
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
エタネルセプト（遺伝子組換え）［エタネルセプト後続１］ in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBENEPALISamsung Bioepis NL B.V., Delft
- FinlandBenepaliSAMSUNG BIOEPIS NL B.V.
- BelgiumBenepali 25 mgSamsung Bioepis NL
- SwitzerlandBenepali
- IrelandBenepali 25 mg solution for injection in pre-filled syringeSamsung Bioepis NL B.V.
- SwedenBenepali 25 mg Injektionsvätska, lösning i förfylld sprutaSamsung Bioepis NL B.V.
- IcelandBenepaliSamsung Bioepis NL B.V.
- PolandBenepaliSamsung Bioepis NL B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Enbrel, Enbrel For Paediatric Use
- Liechtenstein · Enbrel, Enbrel For Paediatric Use
- Norway · Enbrel, Enbrel For Paediatric Use
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f07aa8a1-e6a8-4041-8a82-9eb8df847b39 GET /v1/drugs/f07aa8a1-e6a8-4041-8a82-9eb8df847b39?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "５０ｍｇ１ｍＬ１キット",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999448G3023",
"category": "注射薬",
"price_yen": 10463,
"generic_name": "エタネルセプト（遺伝子組換え）［エタネルセプト後続１］",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about エタネルセプト（遺伝子組換え）［エタネルセプト後続１］.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.